Inhalon Collaborates with Celltrion, Inc to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Inhalon Biopharma, a start-up immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating a variety of acute.
Inhalon Biopharma Receives $7 Million from USAMRDC to Study Inhaled Muco-trapping Antibody for the Treatment of COVID-19 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
UC Berkeley lectureship honors professor emeritus Yuan Tseh Lee dailycal.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailycal.org Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
D. One Vision Management Leads $16 Million Series A Investment In PrinterPrezz
December 10, 2020 GMT
NEW YORK (BUSINESS WIRE) Dec 10, 2020
D. One Vision Management with its DOV Singularity Fund, an alternative investment vehicle for investors seeking growth and diversification in tech-empowered future, today announced the addition of PrinterPrezz, the first Medifacturing TM company in the world to its investment portfolio. Through its DOV Singularity Fund, D. One Vision Management served as the lead investor in PrinterPrezz’s recently completed $16 million Series A funding. Other lead investors in the round include Boutique Venture Partners, Berkeley Catalyst Fund while Solvay Ventures served as strategic investor.